Dr. David B. Sable, MD, PHD
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- Tufts University School of Medicine (1996)
- Years since graduation
- 30
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 1,175
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1996Medical school: Tufts University School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
FL license ME91264 -
MOHS-Micrographic Surgery Physician
FL license ME91264 -
Procedural Dermatology Physician
FL license ME91264
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Academic Alliance in Dermatology Inc (46 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,175
- Services billed
- 7,329
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 2,022 | 338 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,071 | 698 |
| Destruction of precancer skin growth, 1 growth | 631 | 453 |
| Biopsy of related skin growth, first growth | 427 | 328 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 380 | 274 |
| Established patient office or other outpatient visit, 30-39 minutes | 213 | 142 |
| Biopsy of related skin growth, each additional growth | 185 | 100 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 175 | 120 |
| Destruction of precancer skin growth, 15 or more growths | 175 | 111 |
| Destruction of skin growth, 1-14 growths | 173 | 154 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Mupirocin Other prescribers in Tampa, FL | 1,558 |
| Cephalexin Other prescribers in Tampa, FL | 616 |
| Triamcinolone Acetonide Other prescribers in Tampa, FL | 347 |
| Clobetasol Propionate Other prescribers in Tampa, FL | 345 |
| Mometasone Furoate Other prescribers in Tampa, FL | 194 |
| Tramadol Hcl Other prescribers in Tampa, FL | 138 |
| Clindamycin Hcl Other prescribers in Tampa, FL | 124 |
| Ketoconazole Other prescribers in Tampa, FL | 124 |
| Clindamycin Phosphate Other prescribers in Tampa, FL | 107 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Tampa, FL | 94 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 27 payments worth $2,478 in total to this clinician.
| Sun Pharmaceutical Industries Inc. | $2,000 |
|---|---|
| AbbVie Inc. | $231 |
| Novartis Pharmaceuticals Corporation | $73.13 |
| Organogenesis Inc. | $37.92 |
| Amgen Inc. | $34.69 |
| Pfizer Inc. | $27.07 |
| Genzyme Corporation | $19.63 |
| Cipher Pharmaceuticals US LLC | $19.55 |
| Consulting Fee | $2,000 |
|---|---|
| Food and Beverage | $478 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. Mar 3, 2025 | Consulting Fee Odomzo · Oncology | $2,000 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.